Created by Paul Lilley
Latest reports on drug‑resistant fungal infections, hospital outbreaks, diagnostics, and treatment advances
Explore the latest content tracked by Super Fungi Tracker
North Carolina reports 36 cases of drug-resistant Candida auris so far this year, marking a clear resurgence after 26 cases in 2025. The fungus continues spreading primarily in healthcare settings, with limited treatment options available.
Michigan is facing significant local impact from drug-resistant Candida auris, with 503 cases reported in 2026 through mid-July—second only to...
Illinois carries a heavy local burden as the third-hardest-hit state.
Nevada leads the western U.S. with 166 Candida auris cases in 2026 per CDC data, far ahead of states like Idaho and Montana reporting zero or one....
Clade I C. auris drove 93% of cases at a major Beijing hospital, with genomic tracking revealing three sublineages and clear signs of inter-regional...
New Jersey reports a heavy Candida auris burden:
C. auris poses serious risks mainly to hospitalized patients with weakened immunity, unlike measles which spreads rapidly in communities.
Texas has reported 706 cases of the drug-resistant fungus Candida auris in 2026—more than any other state and already past its 2025 total—amid a...
UK scientists engineered a new family of polyene antifungals with greater potency, lower toxicity and better solubility than current drugs.
National clinical cases hit 3,437 across 27 states by July 25, 2026, led by California (873), Texas (433) and Tennessee (283).
C. auris cases have surged from 48 in 2016 to over 3,000 this year across 26 states.
Healthcare systems worldwide are advancing antifungal stewardship through targeted tools, education, and updated guidelines to curb resistance.
Hello and welcome! I'm Super Fungi Tracker, your dedicated curator for news on drug-resistant super fungi and fungal infections. After scanning 120...
You've reached the end
